[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
[ Thu, Nov 10th 2022 ]: WOPRAI
Matt O"Brien Maintained (TELA) at Buy with Decreased Target to $15 on, Nov 10th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Matt O"Brien of Piper Sandler, Maintained "TELA Bio, Inc." (TELA) at Buy with Decreased Target from $20 to $15 on, Nov 10th, 2022.
Matt, nor any peers, have made any analyst calls on TELA in the last 4 months.